Maze Therapeutics, Inc. Common Stock Dividends
The next dividend date for Maze Therapeutics, Inc. Common Stock has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Maze Therapeutics, Inc. Common Stock (MAZE)
More About Maze Therapeutics, Inc. Common Stock
Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidney and metabolic diseases in the United States. Its lead programs include MZE829, an oral small molecule inhibitor of apolipoprotein L1, or APOL1, which is in phase II clinical trial for the treatment of patients with APOL1 kidney disease; and MZE782, an oral small molecule inhibitor that is in phase II ready clinical trial for the treatment of phenylketonuria and chronic kidney disease. The company also develops MZE001, an investigational oral small molecule inhibitor of muscle-specific glycogen synthase clinical program for the treatment of Pompe disease. It has a license agreement with Trace Neuroscience, Inc. to discovery research program targets UNC13A; the Shionogi & Co., Ltd to research, develop, manufacture, and commercialize MZE001; and Neurocrine Biosciences, Inc. to discover research program that targets ATXN2. The company was formerly known as Modulus Therapeutics, Inc. and changed its name to Maze Therapeutics, Inc. in September 2018. The company was incorporated in 2017 and is based in South San Francisco, California.
Owning Maze Therapeutics, Inc. Common Stock Stock on the Dividend Date
If you own Maze Therapeutics, Inc. Common Stock stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Maze Therapeutics, Inc. Common Stock stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Maze Therapeutics, Inc. Common Stock stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Maze Therapeutics, Inc. Common Stock stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Maze Therapeutics, Inc. Common Stock dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Maze Therapeutics, Inc. Common Stock Dividends
You can contact us any time if you would like to ask questions about Maze Therapeutics, Inc. Common Stock dividends or anything else related to the stock market.